.svg){kind=small}
Nov-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Avexia has demonstrated consistent performance in the Illinois market, particularly in the Capsules and Topical categories. For four consecutive months, Avexia maintained the second rank in the Capsules category, showing stability with sales figures fluctuating slightly but remaining robust. In the Topical category, Avexia held the leading position across the same period, indicating a strong market presence and consumer preference. However, in the Concentrates category, while the brand improved its ranking from 20th to 17th from August to November, it did not break into the top 15, suggesting room for growth. In contrast, in Massachusetts, Avexia's performance in Concentrates has been less favorable, with a ranking that fell out of the top 30 in September and October, only to recover slightly to 32nd in November.
In Maryland, Avexia has shown notable strength in the Topical category, consistently holding the top rank from September to November. The brand also maintained the second position in the Capsules category throughout the same period, underscoring its strong foothold in these segments. However, Avexia's entry into the Concentrates category in Maryland is relatively recent, with the brand only appearing in the top 30 as of October and improving to 20th by November. Meanwhile, in Ohio, Avexia has maintained a solid position in the Tincture & Sublingual category, consistently ranking third. Despite this, its presence in the Concentrates category was short-lived, as it dropped out of the top 30 after September, suggesting a potential area for strategic focus.
Competitive Landscape
In the Illinois topical cannabis market, Avexia has consistently maintained its top position from August to November 2024, showcasing its dominance despite a gradual decline in sales over these months. This steady leadership is notable given the fluctuating ranks of competitors like Nature's Grace and Wellness and Doctor Solomon's. While Nature's Grace and Wellness was absent from the top 20 in September, it regained its position by October, and Doctor Solomon's oscillated between second and third place, indicating a competitive landscape. These dynamics suggest that while Avexia's sales are experiencing a downward trend, its strong brand presence and customer loyalty continue to secure its leading rank amidst competitors who are struggling to maintain consistent performance.
Notable Products
In November 2024, Avexia's top-performing product remains the CBD/THC 1:1 Harmony Pain Relief Balm (100mg CBD, 100mg THC, 2oz) in the Topical category, maintaining its first-place ranking consistently since August. The CBD/THC 4:1 Relief Tablets 40-Pack (400mg CBD, 100mg THC) also held steady in second place, with sales increasing to 3630 units. The CBN/CBD/THC 1:1:1 Comfort Tablets 40-Pack (100mg CBN, 100mg CBD, 100mg THC) retained its third-place position, showing stability across the months. The CBG/THC 1:1 Balance Tablets 40-Pack (100mg CBG, 100mg THC) moved up to fourth place in October and maintained this rank in November. Finally, the CBD/THC 1:1 Harmony Micro-Dosed Tablets 40-Pack (100mg CBD, 100mg THC) slipped from fourth to fifth place in October and remained there in November.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
